Clinical Trial Insights On Jujube Camp Extract Chapter 2
Midday energy slump | Incorporate jujube cAMP powder in ready-to-drink (RTD) energy beverages | C-Market: Major dairy launches Jujube Milk line in China with added cAMP for sustained energy. |
Slow post-workout recovery | Add GenoVive to post-exercise yogurt cups | C-Market: Regional yogurt brand releases Jujube Yogurt-consumer repurchase up 20%. |
High-altitude oxygen fatigue | Formulate jujube cAMP shots for mountaineers | B-Customer: European sports nutrition firm PeakFuel boosted sales 30% with cAMP shots. |
Dairy flavor & stability challenges | Micro-encapsulate cAMP into almond-based jujube beverages | C-Market: Plant-milk producer rolls out Jujube Almond Drink with stable cAMP suspension. |
Natural allergy modulation | Develop chewable jujube cAMP gummies | B-Customer: Wellness brand AllerEase saw a 15% drop in itching episodes among users. |
These successful applications underscore jujube cAMP's versatility across Jujube Extract Powder, supplements, and functional dairy formats.
Chapter 2:Preclinical Pharmacodynamics of Jujube cAMP Extract1. Anti-Fatigue Efficacy
In a forced-swim mouse model, jujube cAMP extract delivered dose-dependent endurance gains:
Control: 16.1 ± 1.8 min
Rhodiola (positive control): 26.3 ± 1.0 min
Jujube cAMP 6.7 mL/kg: 20.7 ± 5.7 min*
Jujube cAMP 20 mL/kg: 22.9 ± 4.9 min**
p < 0.05 ** p < 0.01
2. Enhanced Recovery
Rats given jujube cAMP extract before a 30 min swim showed:
Serum lactic acid ↓ 16%
Serum urea nitrogen ↓ 37%
Liver glycogen ↑ 31%
3. Hypoxia Tolerance
Under simulated acute hypoxia:
Control: 38.8 ± 4.2 min
Rhodiola: 52.0 ± 13.7 min*
Jujube cAMP 20 mL/kg: 70.0 ± 9.4 min*
p < 0.05
4. Anti-Allergy Trends
High-dose jujube cAMP extract reduced ear-swelling in dextran and DNFB challenge models, indicating potential in allergy-support formulations.
Data Snapshot
Forced-swim time (min) | 16.1 ± 1.8 | 26.3 ± 1.0** | 22.9 ± 4.9** |
Serum lactic acid (mmol/L) | 12.95 ± 1.88 | 9.36 ± 2.32* | 10.51 ± 1.62* |
Liver glycogen (mg/g) | 8.97 ± 1.58 | 11.89 ± 1.78* | 11.72 ± 1.54* |
Hypoxia survival (min) | 38.8 ± 4.2 | 52.0 ± 13.7* | 70.0 ± 9.4* |
p < 0.05 ** p < 0.01
Implications for R&D: These preclinical results reinforce jujube cAMP's role as a versatile, natural bioactive for:
Health supplements
Functional beverages
Nutritional supplement manufacturing
B2B health products targeted at energy, recovery, and oxygen support

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Daytrading Publishes New Study On The Dangers Of AI Tools Used By Traders
- Primexbt Launches Empowering Traders To Succeed Campaign, Leading A New Era Of Trading
- Wallpaper Market Size, Industry Overview, Latest Insights And Forecast 2025-2033
- Excellion Finance Scales Market-Neutral Defi Strategies With Fordefi's MPC Wallet
- ROVR Releases Open Dataset To Power The Future Of Spatial AI, Robotics, And Autonomous Systems
- Ethereum-Based Meme Project Pepeto ($PEPETO) Surges Past $6.5M In Presale
Comments
No comment